Trial intelligence / Profile preview

Sertraline to Prevent Mood Disorders After TBI

NCT00704379Phase 3Completed

Sponsor
Baylor College of Medicine
Start
Jun 2008
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sertraline in mood disorder, anxiety disorders, sponsored by Baylor College of Medicine. Started Jun 2008; status: completed.

02

Drugs

sertraline
03

Conditions

mood disorderanxiety disorders

Beyond the preview

Go deeper on NCT00704379.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00704379.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call